31 July NAV15 Aug 2013 15:48
Synergy Pharmaceuticals Inc. 277,748 9.52% Summit Corporation plc 212,500 7.29% Arrowhead Research 207,364 7.11% Plethora Solutions Holdings plc 166,625 5.71% TrovaGene Inc. 137,224 4.70% Pfizer Inc. 136,562
4.68% Nektar Therapeutics 127,303 4.36% Sanofi-ADR 91,349 3.13%.
31/7/13 NAV 10.63 p per share.
1,356,675
46.51%
Aggregate value of remaining holdings below 3% of total portfolio
1,560,255
53.49%
TOTAL INVESTMENTS
2,916,930
100.00%